Newsletters | BetaKit

By Alex Riehl March 28, 2024

H|T: The Healthtech Times – AstraZeneca pays $2B for Hamilton biopharma firm

Plus: Neuralink’s first human subject shows off abilities on livestream.

By Alex Riehl March 28, 2024

Plus: Sonder faces class action, Busbud continues LATAM push.

By Alex Riehl March 27, 2024

Plus: Canada’s underinvestment in computing threatens its AI advantage.

By Alex Riehl March 26, 2024

Plus: NowVertical resolves dispute with founder and Reddit’s big debut.

By Alex Riehl March 25, 2024

Plus: Nuvei confirms it is in takeover talks.

By Bianca Bharti March 25, 2024

Plus: CDPQ quietly shutters $250-million D&I fund.

By Alex Riehl March 22, 2024

Plus: Healthcare startup Tempus preps for IPO.

By Alex Riehl March 21, 2024

Plus: Plenty of Fish founder Markus Frind catches new CEO gig.

By Alex Riehl March 20, 2024

Plus: Canada may be losing ground in AI research race.

By Alex Riehl March 19, 2024

Plus: MDF Commerce agrees to go private, but some shareholders raise a fuss.

By Alex Riehl March 18, 2024

Plus: Open banking framework is coming, but adoption? Not so soon.

By Bianca Bharti March 18, 2024

Plus: BetaKit has the exclusive on two new Canadian AI-focused VCs.

By Alex Riehl March 15, 2024

Plus: Vancouver looks to join the global big leagues of modern medicine.

By Alex Riehl March 14, 2024

Plus: Travel perks platform Plusgrade gets a new major investor.

By Alex Riehl March 13, 2024

Plus: Feds intend to move on AI legislation without industry consultation.